Medline Inc. is 1.7x more valuable than RESMED INC by market capitalization ($49.12 B vs $28.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MDLN | RMD |
|---|---|---|
| Market cap | $49.12 B | $28.08 B |
| US-listed rank | #322 | #490 |
| Revenue (latest FY) | $28.43B | $5.15B |
| Net income (latest FY) | $1.16T | $1.40B |
| Net margin | 4069.4% | 27.2% |
| P/E (trailing FY) | 0.0 | 20.0 |
| SEC filings | 103 | 2,518 |
Medline Inc. is 1.7x more valuable than RESMED INC by market capitalization ($49.12 B vs $28.08 B).
In their latest fiscal years, Medline Inc. reported $28.43B in revenue while RESMED INC reported $5.15B.
Full pages: Medline Inc. and RESMED INC, or browse the full rankings.